READ THE PAPER: http://bit.ly/2Wr6NZG
The prognosis of functional limb weakness is unclear. Gelauff et al. report low misdiagnosis rates, higher than expected mortality rates, and mostly persistent and disabling symptoms after 14 years of followup, comparable to neurological controls. These findings inform clinicians of realistic outcomes and emphasise the need for targeted therapy.